ARMATA PHARMACEUTICALS, INC. Foreign Currency Transaction Gain (Loss), Realized
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Foreign Currency Transaction Gain (Loss), Realized of -$113.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2014-11-14
- ARMATA PHARMACEUTICALS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2014-09-30 was -$93.00K.
- ARMATA PHARMACEUTICALS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2014-06-30 was -$16.00K.
- ARMATA PHARMACEUTICALS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2014-03-31 was -$4.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$109.00K derived: sum of 2 quarters · filed 2014-11-14 | -$113.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-09-12 | -$20.00K 10-Q · filed 2014-09-12 | ||
| 2014-03-31 | -$4.00K 10-Q · filed 2014-09-12 | |||
| 2013-12-31 | $41.00K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |